Lv41
590 积分 2024-01-29 加入
Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis
11小时前
已完结
PR031/#1199 Phase I, two-part, mutlicenter, first-in-human (FIH) study of TORL-1–23, a novel claudin 6 (CLDN6) targeting antibody drug conjugate (ADC) in patients with advanced solid tumors
7天前
已关闭
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
1个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
1个月前
已完结
Tissue factor: a neglected role in cancer biology
2个月前
已完结
An overview of anticancer platinum N-heterocyclic carbene complexes
3个月前
已完结
Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
4个月前
已完结
皖公网安备34019202002308
